Obesity is a complex condition that affects far more than weight alone. It is closely connected to liver health and conditions such as metabolic dysfunction-associated steatohepatitis (MASH) which often progresses without noticeable symptoms. Stories like Mr Wang’s shine a light on these silent changes and show how early diagnosis can make a meaningful difference 👇. #LifeForward #WorldObesityDay
Boehringer Ingelheim
Arzneimittelherstellung
Ingelheim am Rhein, Rhineland-Palatinate 2.203.199 Follower:innen
Info
Unsere Mitarbeitenden sind unsere Stärke. Gemeinsam mit über 54.000 Kolleg*innen schaffen wir den nächsten Durchbruch: neue Innovationen für die Gesundheit von Menschen und Tieren. Datenschutzerklärung: https://www.boehringer-ingelheim.com/de/datenschutzerklaerung-0 Impressum: Imprint | Boehringer Ingelheim
- Website
-
http://www.boehringer-ingelheim.com
Externer Link zu Boehringer Ingelheim
- Branche
- Arzneimittelherstellung
- Größe
- 10.001+ Beschäftigte
- Hauptsitz
- Ingelheim am Rhein, Rhineland-Palatinate
- Art
- Privatunternehmen
- Spezialgebiete
- Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals und Contract Manufacturing
Orte
Beschäftigte von Boehringer Ingelheim
Updates
-
#NEWS: Autoimmune and inflammatory diseases affect millions, and many still struggle to achieve lasting disease control. The license agreement with Sitryx adds a potential first-in-class program to our immunology pipeline, aiming to develop oral precision therapies to improve outcomes for these patients. Learn more: https://lnkd.in/dui_mc56 #DrugDevelopment #PrecisionMedicine #InflammatoryDiseases
-
-
#NEWS: We now rank among the top 5% of all evaluated companies, earning a gold medal in the EcoVadis sustainability assessment. EcoVadis is one of the world’s largest providers of comprehensive, evidence-based corporate sustainability ratings. This recognition highlights a key milestone in our ongoing commitment to a healthier, more sustainable future. Explore the details, here: https://lnkd.in/dqJCZBDz #Sustainability #ESG #EcoVadis #Impact https://lnkd.in/d84UTzCq
-
Ready to shape the future of oncology care? As a Global Medical Manager for our pipeline portfolio in oncology, you’ll play a key role in advancing our future oncology innovations and shaping strategic medical excellence. Your key responsibilities: 🟢 Lead medical strategy for the global oncology pipeline portfolio 🟢 Drive evidence generation and contribute to integrated evidence plans 🟢 Deliver a clear, credible scientific narrative across internal and external stakeholders Ready to leave your mark on the future of cancer treatment? Explore the role: https://lnkd.in/d2KX2HQP
-
-
Behind every patient story is a commitment to safety – help us write the next chapter. ✍️ We are seeking an experienced (Senior) Safety Physician to join our team! We’re particularly interested in physicians with expertise in cardiovascular, renal, or metabolic diseases. Your role entails: 🟢 Designing & implementing strategies to generate appropriate safety evidence 🟢 Developing & contributing to patient-centric risk minimization strategies 🟢 Panning, managing & monitoring Pharmacovigilance activities Ready to step into a role that empowers you to truly impact patient safety? 👉 https://lnkd.in/dX6AmMNj
-
-
Computational science and artificial intelligence are reshaping how we discover medicines. In a new Nature Magazine article, we share why embedding data science across our research helps uncover hidden genetic links. It helps us deepen our understanding of disease biology, open new paths to treatments, and accelerate insights that matter for patients. 🔗 Read more: https://lnkd.in/eKbWvW_n #DrugDiscovery #ComputationalBiology
-
-
Do you want to know, how we are using computational sciences & AI to transform pharmaceutical research? We are embedding computational biology, AI and big data into every step of pharmaceutical R&D. From AI-driven target identification and molecular design to advanced simulations and virtual modeling, we are accelerating innovation and paving the way for precision medicine. By combining computational innovation with global collaboration, we move faster, make smarter decisions and deliver live-changing therapies for patients with unmet medical needs. Learn more about how we are shaping the future of medicine through computational innovation: 👉 https://lnkd.in/dpHn76X8
-
-
Did you know AI is helping us predict patient needs faster than ever - while keeping their data safe? Our global governance framework and guiding principles for our partners and employees help ensure responsible and compliant use of Artificial Intelligence. For example, our supplier code of conduct now covers - besides data protection - AI-specific requirements. That's what we talked about on our Data Protection & AI Day together with Prof. Dr. Dieter Kugelmann, State Commissioner for Data Protection in Rhineland-Palatinate. #ResponsibleAI #LifeForward
-
-
#NEWS: New Phase II trial results in primary focal segmental glomerulosclerosis (FSGS) published in The Lancet. Primary FSGS is a rare, progressive kidney disease which can end in kidney failure. Read more 👉 https://lnkd.in/diEVT85J #LifeForward
-
#NEWS: We’ve joined forces with Simcere Pharmaceutical Group (先声药业) to advance a novel bispecific antibody. The compound targets two core pathways driving the onset and progression of inflammatory bowel disease, a lifelong, progressive condition. This unique approach combines two validated pathways in one molecule – striving to deliver better, simpler treatment options for patients. Learn more: https://lnkd.in/dNa9e8sq #IBD #Partnership
-